OAMES associate member Coloplast is asking for DME providers to take a quick survey to better understand Medicare billing for A4353 specific to qualification under immunosuppression. If you are a DME provider that offers A4353 to Medicare beneficiaries, please consider taking the brief 10-question online survey. To eliminate duplication of responses, they ask that only one survey is completed per DME company.
Survey responses are due no later than Friday, February 3.
Click here for background information. If you have any questions about the survey, please reach out to Anna Markiewicz at usanma@coloplast.com or Jason Morin at usjamor@coloplast.com.